Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alexandra D. Palladina"'
Autor:
Alexandra D. Palladina, Aleksandr V. Popa, Timur T. Valiev, Valentin G. Nikitaev, Olga A. Chernysheva, Natalia A. Kupryshina, Irina N. Serebryakova, Tamara V. Shvedova, Konstantin L. Kondratchik, Nikolai N. Tupitsyn
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 148-155 (2021)
Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia (AML), which is associated with poor prognosis for all patients except children with t(1;22) or Down syndrome. The frequency of complete remission in case of AMKL is c
Externí odkaz:
https://doaj.org/article/da34523d644c47bfa0efb92a4a548e46
Autor:
N. A. Kupryshina, N. V. Lepkova, O. P. Kolbatskaya, Alexandra D. Palladina, A. M. Kozhonalieva, A. V. Egorova, I. S. Stylidi, S. V. Chulkova, I. V. Poddubnaya, K. I. Zhordania, N. N. Tupitsyn, I. I. Bokin, E. V. Artamonova
Publikováno v:
Medical alphabet. :39-45
Introduction. An important aspect of cancer treatment today is the concept of immuno-targeted therapy, which requires a deep understanding of the characteristics of immune reactions in the body of a cancer patient. Bone marrow is the central organ of
Autor:
Irina N. Serebryakova, Tamara V. Shvedova, Alexandra D. Palladina, Aleksandr V. Popa, T T Valiev, Nikolai N. Tupitsyn, Olga Chernysheva, N. A. Kupryshina, V. G. Nikitaev, Konstantin L. Kondratchik
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 148-155 (2021)
Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia (AML), which is associated with poor prognosis for all patients except children with t(1;22) or Down syndrome. The frequency of complete remission in case of AMKL is c
Autor:
T. M. Djumanazarov, Alexandra D. Palladina, N. A. Kupryshina, S. S. Gerasimov, NN Tupitsyn, A. K. Allakhverdiev, P. V. Kononetz, B. B. Akhmedov, Olga Chernysheva, O. P. Kolbatskaya, S. V. Chulkova
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 94-99 (2020)
Introduction.Detection of disseminated tumor cells (DTC) in solid tumors is an important component of the assessment of disease prognosis. Bone marrow damage is common. There is evidence indicating an important role for bone marrow lymphocyte subpopu
Publikováno v:
Онкогинекология. :23-30
Autor:
Olga Chernysheva, Igor K. Vorotnikov, Alexandra D. Palladina, N. N. Tupitsyn, Vanui A. Mkrtchyan
Publikováno v:
Онкогинекология. :4-13
Autor:
Alina Antipova, Nikolai N. Tupitsyn, Lev Demidov, Olga Chernysheva, N. A. Kupryshina, Alexandra D. Palladina, S. V. Chulkova, Irina Markina
Publikováno v:
Cells
Volume 8
Issue 6
Cells, Vol 8, Iss 6, p 627 (2019)
Volume 8
Issue 6
Cells, Vol 8, Iss 6, p 627 (2019)
Disseminated tumor cells (DTCs) are studied as a prognostic factor in many non-hematopoietic tumors. Melanoma is one of the most aggressive tumors. Forty percent of melanoma patients develop distant metastases at five or more years after curative sur